Direct Healthcare Professional Communication (DHPC) on Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL

The Federal Institute for Drugs and Medical Devices (BfArM) has released important information regarding the pharmacovigilance of Voxzogo® (vosoritide).

The latest update pertains to a change in the administration syringe and needle, resulting in product administration now measured in Units (U) instead of mL. This change is aimed at enhancing the precision and accuracy of dosage administration.

BfArM, being the authority responsible for drug safety in Germany, would like to ensure that this vital information reaches all healthcare professionals directly. 

Read more here:


Get In Touch

We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.

Thank you we will get back to you shortly!

MO - FR 9:00 am - 5:00 pm

+ 420 774 557 550


Czech Republic,
Nile House, Karolinská 654/2, Karlín, 186 00, Prague